NAD+ Treatment Can Block Rotenone‐induced Nuclear Apoptotic Changes of PC12 Cells

Yunyi Hong,Jiaxiang Shao,Weiliang Xia,Weihai Ying
DOI: https://doi.org/10.1096/fasebj.24.1_supplement.965.6
2010-01-01
Abstract:Our previous study has shown that NAD+ can prevent astrocyte necrosis induced by oxidative stress and DNA alkylating agents. We have further found that intranasal administration of NAD+ can profoundly reduce ischemic brain damage. The goal of this current study is to determine the effects of NAD+ on the apoptotic changes of cells. We found that the mitochondrial Complex I inhibitor rotenone at 0.1 to 1 micromolar dose‐dependently induced nuclear condensation of PC12 cells: 0.75 micromolar rotenone induced an approximately 50% decrease in the nuclear size of the cells. Treatment of the cells with 0.25 to 1 mM NAD+ dose‐dependently attenuate rotenone‐induced nuclear condensation ‐‐‐ a hallmark of apoptosis: the rotenone‐induced nuclear condensation was nearly completely prevented by 1 mM NAD+. Our preliminary results have also shown that NAD+ treatment can prevent alkylating agent‐induced DNA laddering of astrocytes. Collectively, our results suggest that NAD+ treatment can significantly decrease toxic agent‐induced necrosis as well as apoptotic changes, thus providing information for understanding the mechanisms underlying the NAD+‐produced reductions of ischemic brain injury (Supported by a Key Research Grant of Shanghai Municipal Scientific Committee 08JC1415400 (WY), Pujiang Scholar Program Grant (WY)).
What problem does this paper attempt to address?